Quick Answer
FATE THERAPEUTICS INC reported Common Stock Shares Outstanding of 115.36 million shares for the year ending 2025.
- FATE THERAPEUTICS INC showed an increase of +1.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), FATE THERAPEUTICS INC's Common Stock Shares Outstanding has grown by 8,546.9%.
- Historical annual values: Fiscal year 2025: 115.36 million shares | Fiscal year 2024: 113.93 million shares | Fiscal year 2023: 98.63 million shares | Fiscal year 2022: 97.29 million shares | Fiscal year 2021: 95.73 million shares | Fiscal year 2020: 87.72 million shares | Fiscal year 2019: 75.73 million shares | Fiscal year 2018: 64.69 million shares | Fiscal year 2017: 52.65 million shares | Fiscal year 2016: 41.39 million shares | Fiscal year 2015: 28.72 million shares | Fiscal year 2014: 20.57 million shares | Fiscal year 2013: 20.43 million shares | Fiscal year 2012: 1.33 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: